BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18360707)

  • 1. Alterations in human breast cancer adhesion-motility in response to changes in cell surface glycoproteins displaying alpha-L-fucose moieties.
    Yuan K; Kucik D; Singh RK; Listinsky CM; Listinsky JJ; Siegal GP
    Int J Oncol; 2008 Apr; 32(4):797-807. PubMed ID: 18360707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell surface associated alpha-L-fucose moieties modulate human breast cancer neoplastic progression.
    Yuan K; Listinsky CM; Singh RK; Listinsky JJ; Siegal GP
    Pathol Oncol Res; 2008 Jun; 14(2):145-56. PubMed ID: 18553163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation, and ERK1/2 and p38 MAPK activation.
    Carrascal MA; Silva M; Ramalho JS; Pen C; Martins M; Pascoal C; Amaral C; Serrano I; Oliveira MJ; Sackstein R; Videira PA
    Mol Oncol; 2018 May; 12(5):579-593. PubMed ID: 29215790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of terminal sugar residues of surface glycans in the metastatic potential of human hepatocarcinoma.
    Zhang Y; Zhang XY; Liu F; Qi HL; Chen HL
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):617-20. PubMed ID: 12458342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential classes of glycoligands mediating dynamic endothelial adhesion of human tumor cells.
    Starzonek S; Maar H; Mereiter S; Freytag V; Haider MT; Riecken K; Huang YL; Jacob F; Wicklein D; Schumacher U; Lange T
    Glycobiology; 2023 Oct; 33(8):637-650. PubMed ID: 37486674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human a-L-fucosidase-1 attenuates the invasive properties of thyroid cancer.
    Vecchio G; Parascandolo A; Allocca C; Ugolini C; Basolo F; Moracci M; Strazzulli A; Cobucci-Ponzano B; Laukkanen MO; Castellone MD; Tsuchida N
    Oncotarget; 2017 Apr; 8(16):27075-27092. PubMed ID: 28404918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adhesion of head and neck squamous cell carcinoma to endothelial cells. The missing links.
    Wenzel CT; Scher RL; Richtsmeier WJ
    Arch Otolaryngol Head Neck Surg; 1995 Nov; 121(11):1279-86. PubMed ID: 7576475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocyte Adhesion Deficiency Type II is a generalized defect of de novo GDP-fucose biosynthesis. Endothelial cell fucosylation is not required for neutrophil rolling on human nonlymphoid endothelium.
    Karsan A; Cornejo CJ; Winn RK; Schwartz BR; Way W; Lannir N; Gershoni-Baruch R; Etzioni A; Ochs HD; Harlan JM
    J Clin Invest; 1998 Jun; 101(11):2438-45. PubMed ID: 9616215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between rheumatoid arthritis synovial fibroblast migration and endothelial cells.
    Zimmermann-Geller B; Köppert S; Kesel N; Hasseli R; Ullrich S; Lefèvre S; Frommer K; Gehrke T; Schönburg M; Rehart S; Schumacher U; Müller-Ladner U; Neumann E
    Immunol Cell Biol; 2019 Feb; 97(2):178-189. PubMed ID: 30252968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cimetidine inhibits the adhesion of gastric cancer cells expressing high levels of sialyl Lewis x in human vascular endothelial cells by blocking E-selectin expression.
    Liu FR; Jiang CG; Li YS; Li JB; Li F
    Int J Mol Med; 2011 Apr; 27(4):537-44. PubMed ID: 21327325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycoengineering of chimeric antigen receptor (CAR) T-cells to enforce E-selectin binding.
    Mondal N; Silva M; Castano AP; Maus MV; Sackstein R
    J Biol Chem; 2019 Nov; 294(48):18465-18474. PubMed ID: 31628196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic interplay between breast cancer cells and normal endothelium mediates the expression of matrix macromolecules, proteasome activity and functional properties of endothelial cells.
    Gialeli Ch; Viola M; Barbouri D; Kletsas D; Passi A; Karamanos NK
    Biochim Biophys Acta; 2014 Aug; 1840(8):2549-59. PubMed ID: 24582970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of macrophage-mediated cytotoxicity: role of target and effector cell fucose.
    Cameron DJ
    Immunol Lett; 1985; 11(1):39-44. PubMed ID: 4054947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells.
    Zhang K; Baeckström D; Brevinge H; Hansson GC
    J Cell Biochem; 1996 Mar; 60(4):538-49. PubMed ID: 8707893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells.
    Zipin A; Israeli-Amit M; Meshel T; Sagi-Assif O; Yron I; Lifshitz V; Bacharach E; Smorodinsky NI; Many A; Czernilofsky PA; Morton DL; Witz IP
    Cancer Res; 2004 Sep; 64(18):6571-8. PubMed ID: 15374970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgene expression of alpha(1,2)-fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin.
    Mathieu S; Prorok M; Benoliel AM; Uch R; Langlet C; Bongrand P; Gerolami R; El-Battari A
    Am J Pathol; 2004 Feb; 164(2):371-83. PubMed ID: 14742243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-asparaginase inhibits invasive and angiogenic activity and induces autophagy in ovarian cancer.
    Yu M; Henning R; Walker A; Kim G; Perroy A; Alessandro R; Virador V; Kohn EC
    J Cell Mol Med; 2012 Oct; 16(10):2369-78. PubMed ID: 22333033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a spontaneously transformed human endothelial cell line.
    Cockerill GW; Meyer G; Noack L; Vadas MA; Gamble JR
    Lab Invest; 1994 Oct; 71(4):497-509. PubMed ID: 7526034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E/P-selectin-deficient mice: an optimal mutation for abrogating antigen but not tumor necrosis factor-alpha-induced immune responses.
    McCafferty DM; Kanwar S; Granger DN; Kubes P
    Eur J Immunol; 2000 Aug; 30(8):2362-71. PubMed ID: 10940927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin.
    Dimitroff CJ; Lechpammer M; Long-Woodward D; Kutok JL
    Cancer Res; 2004 Aug; 64(15):5261-9. PubMed ID: 15289332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.